Skip to content
Home » News

News

A short video has been developed by the project team to explain what research consent entails

    A short video has been developed by the project team to explain what research consent entails Presented by Dr. Guillaume Marquis-Gravel, cardiologist and researcher at the Montreal Heart Institute, this video defines the concepts of informed, voluntary, and ongoing consent. Additionally, it informs potential participants… Read More »A short video has been developed by the project team to explain what research consent entails

    Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal

      Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal (This article is available exclusively in French) Le Dr Jean-Claude Tardif, directeur du Centre de recherche de l’Institut de cardiologie de Montréal et professeur titulaire de médecine à l’Université de Montréal,… Read More »Jean-Claude Tardif is the winner of the Desmond Julian Prize from the European Heart Journal

      Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics

        Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics Most people would likely agree that the healthcare industry is in need of a good shakeup, particularly in the domains of disease screening and diagnostics.… Read More »Article by Karim Aly, CEO of our partner Noze – AI Powered Breath Analysis for Early Disease Screening & Diagnostics

        Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine.

          Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine. A real math and biology whiz, Dr. Dubé first developed a keen interest in genetics during university. “I fell in love with genetics. I saw it as… Read More »Blog – Dr. Marie-Pierre Dubé, director of the MHI’s Pharmacogenomics Centre, a project partner, talks about precision medicine.

          A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States.

            A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States. THIS ARTICLE IS AVAILABLE EXCLUSIVELY IN FRENCH La FDA des États-Unis a approuvé la semaine dernière la colchicine à… Read More »A study from the Montreal Heart Institute, led by Dr. Tardif, principal investigator of our project, is behind the approval of colchicine in the United States.

            Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development 

              Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development  Perceiv AI, an AI-driven precision medicine company, today announced that it has joined Johnson & Johnson Innovation–JLABS, a premier life science incubator program. Perceiv AI will gain access to a… Read More »Perceiv AI Joins Johnson & Johnson Innovation–JLABS Global Network to Accelerate Precision Medicine Platform Development 

              Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector

                Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector Supporting innovative projects contributes to economic development in Quebec’s regions. That is why the Member of Parliament for Compton–Stanstead and Minister of Agriculture and Agri‑Food, the Honourable Marie‑Claude Bibeau, is today announcing, on… Read More »Government of Canada supports Omnimed and its unique project in Quebec’s digital health sector